Brind.

FDA approved Benlysta autoinjector for pediatric lupus nephritis, a treatment option discussed by the Lupus Foundation of America.

1 report, 0 independent Updated Jun 24

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

GSK FDA Lupus Foundation of America

Keep exploring

The entities involved

GSK
British multinational pharmaceutical and biotechnology company
- HCRx buys into Utebzi milestones and royalties, GSK grants exclusive license for Utebzi, and Spero in-licenses SP001 from Innovent Biologics.Fri 07:57
- GSK out-licensed the commercialization rights for Spero Therapeutics' first drug.Fri 07:57
FDA
- The illegal U.S. vape market is estimated to be worth $9 billion, fueled by unauthorized imports from China, while products must meet FDA authorization standards.Sun 20:36
- VDPHL01 and Veradermics, Incorporated are seeking FDA approval for their lead therapies targeting hair loss.Sun 20:31
Lupus Foundation of America
organization

Nothing else this week.

Coverage

Newest first; wire copies grouped

Jun 24Unknown outlet